How does ICER plan to find out whether or not well being plans provide truthful entry to prescribed drugs? I summarized their method final yr as outlined of their white paper titled “Cornerstones of ‘Honest’ Drug Protection: Acceptable Value-Sharing and Utilization Administration Insurance policies for Prescribed drugs.” Final month, closing protocol for his or her “Limitations to Honest Entry Evaluation“. Whereas the method follows their earlier protocol and white paper, not all all the standards on this white paper are being evaluated. Which standards is ICER evaluating? I’ve summarized the standards ICER plans to incorporate and exclude of their “Honest Entry” evaluation under.